Center-Authored Papers

Filters: Author is Rosty, Christophe  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
United States
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Specimen Processing Core Facility
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Specialized Pathology Core Facility
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Smoking
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
Shared Resources
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Sex Factors
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
September 2012
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Scientific Imaging Core Facility
Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M et al..  2015.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.. Gut. 64(1):101-10. Abstract
Weisenberger DJ, Levine JA, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L et al..  2015.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(3):512-9. Abstract
Risk Factors
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
Registries
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Public Health Sciences Division
Clendenning M, Walsh MD, Gelpi JB, Thibodeau SN, Lindor N, Potter JD, Newcomb P, Le Marchand L, Haile R, Gallinger S et al..  2013.  Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Familial cancer. 12(3):563-6. Abstract
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG et al..  2014.  Risk of Colorectal Cancer for Carriers of Mutations in MUTYH, with and without a Family History of Cancer.. Gastroenterology. Abstract
Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M et al..  2015.  Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.. Gut. 64(1):101-10. Abstract
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I et al..  2012.  Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.. Journal of the National Cancer Institute. 104(18):1363-72. Abstract
Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler BN, Pearson S-A, Macrae F, Parry S, Arnold J et al..  2013.  Family History of Colorectal Cancer in BRAF p.V600E mutated Colorectal Cancer Cases.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J et al..  2013.  Risks of colorectal and other cancers after endometrial cancer for women with lynch syndrome.. Journal of the National Cancer Institute. 105(4):274-9. Abstract
Roberts A, Nancarrow D, Clendenning M, Buchanan DD, Jenkins MA, Duggan D, Taverna D, McKeone D, Walters R, Walsh MD et al..  2011.  Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome).. Familial cancer. 10(2):245-54. Abstract
Proportional Hazards Models
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Prevalence
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Odds Ratio
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ et al..  2010.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.. PloS one. 5(7):e11636. Abstract
Nuclear Proteins
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
MutS Homolog 2 Protein
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract
Middle Aged
Ouakrim DA, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B et al..  2015.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.. Journal of the National Cancer Institute. 107(9) Abstract